Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7699 USD | +0.55% | +3.00% | -18.74% |
Financials (USD)
Sales 2024 * | 2M | Sales 2025 * | 3.33M | Capitalization | 56.05M |
---|---|---|---|---|---|
Net income 2024 * | -94M | Net income 2025 * | -106M | EV / Sales 2024 * | 28 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 16.8 x |
P/E ratio 2024 * |
-0.62
x | P/E ratio 2025 * |
-0.63
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.16% |
Latest transcript on Kezar Life Sciences, Inc.
1 day | +0.55% | ||
1 week | +3.00% | ||
Current month | -6.62% | ||
1 month | -2.54% | ||
3 months | -6.86% | ||
6 months | -13.02% | ||
Current year | -18.74% |
Managers | Title | Age | Since |
---|---|---|---|
Christopher Kirk
FOU | Founder | 52 | 15-02-18 |
John Fowler
FOU | Founder | 52 | 15-02-18 |
Marc Belsky
DFI | Director of Finance/CFO | 68 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 16-10-31 |
Graham Cooper
CHM | Chairman | 54 | 17-09-30 |
Michael Kauffman
BRD | Director/Board Member | 60 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +9.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 0.7699 | +0.55% | 563,761 |
24-05-17 | 0.7657 | -0.30% | 266,034 |
24-05-16 | 0.768 | -0.56% | 623,270 |
24-05-15 | 0.7723 | -2.18% | 425,070 |
24-05-14 | 0.7895 | +5.62% | 1,219,718 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.74% | 56.05M | |
+9.58% | 115B | |
+12.41% | 107B | |
-2.59% | 21.6B | |
-12.38% | 22.31B | |
-5.29% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- KZR Stock